Table 2.
Standardised prevalence of cardiometabolic disease status at baseline
| Overall (n=1 038 704) | Male (n=504 525) | Female (n=534 179) | ||||
| No of cases | % (95% CI) | No of cases | % (95% CI) | No of cases | % (95% CI) | |
| One disease | 85 684 | 9.32 (9.26 to 9.37) | 40 883 | 8.64 (8.57 to 8.72) | 44 801 | 10.01 (9.93 to 10.09) |
| HT | 69 406 | 7.60 (7.55 to 7.65) | 32 697 | 6.96 (6.89 to 7.02) | 36 709 | 8.25 (8.18 to 8.33) |
| DM | 14 127 | 1.49 (1.46 to 1.51) | 6992 | 1.43 (1.40 to 1.47) | 7135 | 1.54 (1.51 to 1.58) |
| CVD | 2151 | 0.23 (0.22 to 0.24) | 1194 | 0.25 (0.24 to 0.27) | 957 | 0.21 (0.20 to 0.23) |
| Two diseases | 22 871 | 2.57 (2.54 to 2.60) | 10 349 | 2.24 (2.20 to 2.29) | 12 522 | 2.90 (2.85 to 2.95) |
| HT+DM | 11 073 | 1.26 (1.24 to 1.29) | 4722 | 1.03 (1.00 to 1.06) | 6351 | 1.50 (1.46 to 1.53) |
| HT+CVD | 11 540 | 1.28 (1.25 to 1.30) | 5481 | 1.18 (1.15 to 1.21) | 6059 | 1.38 (1.34 to 1.41) |
| DM+CVD | 258 | 0.03 (0.02 to 0.03) | 146 | 0.03 (0.03 to 0.04) | 112 | 0.03 (0.02 to 0.03) |
| Three diseases | 2203 | 0.26 (0.25 to 0.27) | 841 | 0.19 (0.17 to 0.20) | 1362 | 0.33 (0.31 to 0.35) |
CVD, cardiovascular disease; DM, diabetes mellitus; HT, hypertension.